Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: method validation in blood using the total error approach.

Denooz, Raphael; Douamba, Zoénabo; Charlier, Corinne

doi:10.1016/j.jchromb.2008.11.049

Article (Scientific journals)

Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: method validation in blood using the total error approach.

Denooz, Raphael; Douamba, Zoénabo; Charlier, Corinne

2009 • In Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 877 (23), p. 2344-2348

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/13668

DOI
10.1016/j.jchromb.2008.11.049

PubMed
19144578

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

J Chrom. B, 2009, Fatal intox. antivit. K.pdf

Publisher postprint (754.56 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Anticoagulant drugs; HPLC; Total error

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Denooz, Raphael ; Université de Liège - ULiège > Toxicologie clinique

Douamba, Zoénabo

Charlier, Corinne ; Université de Liège - ULiège > Département de pharmacie > Chimie toxicologique

Language :

English

Title :

Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: method validation in blood using the total error approach.

Publication date :

01 August 2009

Journal title :

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences

ISSN :

1570-0232

eISSN :

1873-376X

Publisher :

Elsevier Science, Amsterdam, Netherlands

Volume :

877

Issue :

Pages :

2344-2348

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 26 January 2010

Statistics

Number of views

95 (18 by ULiège)

Number of downloads

9 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Ufer M. Clin. Pharmacokinet. 44 (2005) 1227
Cesar J.M., Garcia-Avello A., Navarro J.L., and Herraez M.V. Blood Coagul. Fibrin. 15 (2004) 673
Cruickshank J., Ragg M., and Eddey D. Emerg. Med. Australas. 13 (2001) 91
Saraeva R.B., Paskaleva I.D., Doncheva E., Eap C.B., and Ganev V.S. J. Clin. Pharm. Ther. 32 (2007) 641
Penning-van Beest F.J., Koerselman J., and Herings R.M. J. Thromb. Haemost. 6 (2008) 284
van Geest-Daalderop J.H., Hutten B.A., Pequeriaux N.C., De Vries-Goldschmeding H.J., Rakers E., and Levi M. Thromb. Haemost. 98 (2007) 747
Hohler T., Becker J., Meyer zum Buschenfelde K.H., and Rittner C. Int. J. Legal Med. 108 (1996) 268
Schulz M., and Schmoldt A. Pharmazie 12 (1997) 895
Arlenda Home Page, https://www.arlenda.com, e.noval Version V2.0c PROD, March 2008.
Hubert P., Rozet E., Boulanger B., Dewé W., Laurentie M., Dubois N., Charlier C., and Feinberg M. Acta Clin. Belg. 61 (2006) 54
FDA Home Page, Guidance for Industry: Bioanalytical Method Validation, http://www.fda.gov/cder/guidance/4252fnl.htm, June 2008.
Hubert P., et al. J. Pharm. Biomed. Anal. 36 (2004) 579
Hubert P., et al. J. Pharm. Biomed. Anal. 48 (2008) 760